Search for: "FOREST PHARMACEUTICALS, INC.," Results 1 - 20 of 177
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Sep 2010, 8:32 am by fraudfighters
Department of Justice announced that it has entered into a settlement agreement with Forest Pharmaceuticals, Inc. in which Forest will pay more than $313 million to resolve civil and criminal allegations that it engaged in unlawful practices in connection with the sale and marketing of its drugs Levothroid, Celexa, and Lexapro. [read post]
11 Mar 2011, 4:20 am by LaBovick Law
  The pharmaceutical company,  Forest Pharmaceuticals, Inc., was recently fined $164 million for shady marketing techniques, obstructing the FDA, and distributing a drug which had not yet been approved by the FDA. [read post]
17 Sep 2010, 11:11 am by Heather Young
SHARP INCREASE IN WHISTLE-BLOWER ACTIONS EXPECTED AS GOVERNMENT RAMPS UP EFFORTS AGAINST PHARMA COMPANIESFresh off his victory for a whistle-blower in the Forest Pharmaceuticals, Inc. lawsuit, attorney David Stone is setting his sights on the billions of dollars of settlements he expects awarded in future legal actions involving off-labeling marketing practices. [read post]
5 Sep 2007, 8:38 pm
Noonan -- The Federal Circuit today affirmed a District Court finding that ANDA filer Ivax Pharmaceuticals and co-Defendant Cipla had not shown by clear and convincing evidence that Forest Laboratories' patent-in-suit for Lexapro ® was invalid. [read post]
21 Feb 2017, 9:37 am by Green and Associates
 In a recent case, Forest Laboratories LLC, located in New York, New York, and its subsidiary, Forest Pharmaceuticals Inc., agreed in December 2016 to pay $38 million to resolve allegations that they violated the False Claims Act by paying "kickbacks" through payments and meals for alleged sham speaking programs to induce physicians to prescribe the drugs Bystolic®, Savella®, and Namenda®. [read post]
21 Feb 2017, 9:37 am by Green and Associates
 In a recent case, Forest Laboratories LLC, located in New York, New York, and its subsidiary, Forest Pharmaceuticals Inc., agreed in December 2016 to pay $38 million to resolve allegations that they violated the False Claims Act by paying "kickbacks" through payments and meals for alleged sham speaking programs to induce physicians to prescribe the drugs Bystolic®, Savella®, and Namenda®. [read post]
16 Sep 2010, 12:00 pm by Lucas A. Ferrara, Esq.
The Department of Justice also announced that Forest Pharmaceuticals, Inc. and its parent company, Forest Laboratories, Inc., have agreed to pay $149 million and to enter into a Corporate Integrity Agreement with the Office of Inspector General of the U.S. [read post]
23 Mar 2008, 8:45 pm by GenericIPguy
New Litigation filings: Plaintiffs: Forest Laboratories, Inc., Forest Laboratories Holdings, Ltd., Merz Pharmaceuticals GmbH and Merz Pharma GmbH & Co. [read post]
25 Aug 2008, 4:10 am
Forest Laboratories, Inc., and just last week, Prasco LLC v. [read post]